- MyIllumina
- Tools
Combining the proven GoldenGate Genotyping Assay with VeraCode technology provides one of the most robust and flexible platforms for SNP genotyping in the industry. Users benefit from the GoldenGate Assay's accuracy, sensitivity, and high signal-to-noise ratio. Coupled with the unique VeraCode technology, this assay provides superior data quality and high sample throughput at low per-sample costs.
View the product support page for additional technical information ยป
-
The VeraCode GoldenGate Genotyping Kits deliver a highly robust system for high-throughput, custom 48-, 96-, 144-, 192-, and 384-plex SNP genotyping.
-
These kits bundle DNA activation reagents, GoldenGate Assay reagents, a custom OPA, and VeraCode BeadPlates into one convenient kit.
Catalog IDs: VC-201-0048, VC-201-0096, VC-201-0144, VC-201-0192, VC-201-0384
Product Literature
| BeadXpress Reader Data Sheet |
Innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
© 2012 Illumina, Inc. All rights reserved.